Terms: = Germ cell tumor AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Clinical Outcome
23 results:
1. Emerging therapeutic targets for retinoblastoma.
Manukonda R; Narayana RV; Kaliki S; Mishra DK; Vemuganti GK
Expert Opin Ther Targets; 2022 Nov; 26(11):937-947. PubMed ID: 36524402
[TBL] [Abstract] [Full Text] [Related]
2. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
Pratt D; Abdullaev Z; Papanicolau-Sengos A; Ketchum C; Panneer Selvam P; Chung HJ; Lee I; Raffeld M; Gilbert MR; Armstrong TS; Pytel P; Borys E; Klonoski JM; McCord M; Horbinski C; Brat D; Perry A; Solomon D; Eberhart C; Giannini C; Quezado M; Aldape K
Acta Neuropathol; 2022 Mar; 143(3):403-414. PubMed ID: 35103816
[TBL] [Abstract] [Full Text] [Related]
3. Identification of novel rb1 genetic variants in Retinoblastoma patients and their impact on clinical outcome.
Manukonda R; Pujar A; Ramappa G; Vemuganti GK; Kaliki S
Ophthalmic Genet; 2022 Feb; 43(1):64-72. PubMed ID: 34645364
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.
Liverani C; Bongiovanni A; Mercatali L; Pieri F; Spadazzi C; Miserocchi G; Di Menna G; Foca F; Ravaioli S; De Vita A; Cocchi C; Rossi G; Recine F; Ibrahim T
Endocr Pathol; 2021 Jun; 32(2):309-317. PubMed ID: 33409812
[TBL] [Abstract] [Full Text] [Related]
5. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
[TBL] [Abstract] [Full Text] [Related]
6. Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic and Immunohistochemical Analysis of 34 Resected Cases.
Lee SM; Sung CO
Am J Surg Pathol; 2020 Oct; 44(10):1308-1321. PubMed ID: 32739935
[TBL] [Abstract] [Full Text] [Related]
7. Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large cell Neuroendocrine Carcinomas with Distinct Prognosis.
Milione M; Maisonneuve P; Grillo F; Mangogna A; Centonze G; Prinzi N; Pusceddu S; Garzone G; Cattaneo L; Busico A; Bossi P; Spaggiari P; Pellegrinelli A; Del Gobbo A; Ferrero S; Kankava K; Pruneri G; Rolli L; Roca E; Bercich L; Tironi A; Benvenuti MR; Gallazzi MS; Romano R; Berruti A; Pastorino U; Capella C
Neuroendocrinology; 2021; 111(5):475-489. PubMed ID: 32365350
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
Ohmoto A; Rokutan H; Yachida S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
[TBL] [Abstract] [Full Text] [Related]
9. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.
Liu X; Chong Y; Tu Y; Liu N; Yue C; Qi Z; Liu H; Yao Y; Liu H; Gao S; Niu M; Yu R
J Hematol Oncol; 2016 Oct; 9(1):108. PubMed ID: 27733172
[TBL] [Abstract] [Full Text] [Related]
10. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract] [Full Text] [Related]
11. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.
Schrama D; Peitsch WK; Zapatka M; Kneitz H; Houben R; Eib S; Haferkamp S; Moore PS; Shuda M; Thompson JF; Trefzer U; Pföhler C; Scolyer RA; Becker JC
J Invest Dermatol; 2011 Aug; 131(8):1631-8. PubMed ID: 21562568
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of genes in retinoblastoma.
Saxena P; Kaur J
Clin Chim Acta; 2011 Nov; 412(23-24):2015-21. PubMed ID: 20951689
[TBL] [Abstract] [Full Text] [Related]
13. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
Sutter R; Shakhova O; Bhagat H; Behesti H; Sutter C; Penkar S; Santuccione A; Bernays R; Heppner FL; Schüller U; Grotzer M; Moch H; Schraml P; Marino S
Oncogene; 2010 Mar; 29(12):1845-56. PubMed ID: 20062081
[TBL] [Abstract] [Full Text] [Related]
14. Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.
Kramar F; Zemanova Z; Michalova K; Babicka L; Ransdorfova S; Hrabal P; Kozler P
J Neurooncol; 2007 Sep; 84(2):201-11. PubMed ID: 17569001
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic factors for anaplastic astrocytomas.
Compostella A; Tosoni A; Blatt V; Franceschi E; Brandes AA
J Neurooncol; 2007 Feb; 81(3):295-303. PubMed ID: 17001519
[TBL] [Abstract] [Full Text] [Related]
16. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract] [Full Text] [Related]
17. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract] [Full Text] [Related]
18. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
[TBL] [Abstract] [Full Text] [Related]
20. Differential expression of the retinoblastoma gene family members in choroidal melanoma: prognostic significance.
Massaro-Giordano M; Baldi G; De Luca A; Baldi A; Giordano A
Clin Cancer Res; 1999 Jun; 5(6):1455-8. PubMed ID: 10389932
[TBL] [Abstract] [Full Text] [Related]
[Next]
